© 2024 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Cameron Santoro is an associate editor for The Center for Biosimilars®, The American Journal of Managed Care® (AJMC), and AJMC.com.
May 10, 2024
Video
Here are the top 5 biosimilar articles for the week of May 6, 2024.
May 07, 2024
Article
Biosimilars offer a promising path to affordable, effective treatment, but barriers remain for underserved communities. This 2-part series explores the potential of biosimilars to improve health equity while addressing the obstacles that currently prevent access.
May 03, 2024
Video
Here are the top 5 biosimilar articles for the week of April 29, 2024.
April 28, 2024
Video
In an interview with Adam Colborn, JD, director of government relations for the Academy of Managed Care Pharmacy focuses on biosimilar interchangeability and approaches to encourage wider adoption in dispensing these medications.
April 26, 2024
Video
Here are the top 5 biosimilar articles for the week of April 22, 2024.
April 22, 2024
Article
Despite current challenges in biosimilar market growth due to stakeholder disagreements, a recent commentary proposes that applying collective action theory can achieve widespread biosimilar market uptake by fostering collaboration for long-term benefits.
April 21, 2024
Video
Ha Kung Wong, JD, a patent attorney, explores the challenges of "patent thickets" in the biologics market, where a complex web of patents can hinder development of more affordable biosimilar drugs. However, the discussion also highlights mechanisms to ensure fair competition and patient access.
April 19, 2024
Video
Here are the top 5 biosimilar articles for the week of April 15, 2024.
April 14, 2024
Article
Positive results of sintilimab, IBI305, and hepatic arterial infusion chemotherapy (HAIC) treatment showed shrinking tumors and previously converting inoperable hepatocellular carcinoma (HCC) to resectable HCC with manageable adverse effects.
April 12, 2024
Video
Here are the top 5 biosimilar articles for the week of April 8, 2024.